Erbb2 DNA Vaccine Combined with Regulatory T Cell Deletion Enhances Antibody Response and Reveals Latent Low-Avidity T Cells: Potential and Limits of Its Therapeutic Efficacy
暂无分享,去创建一个
P. Musiani | G. Forni | C. Nicoló | M. Iezzi | G. Di Sante | F. Cavallo | M. Spadaro | F. Ria | S. Occhipinti | S. Rolla | E. Ambrosino | I. Merighi